(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE

Star0

DB08416ExperimentalSmall molecule

(9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE: Overview.

Mechanism: Pharmacologically active on Carbonic anhydrase 2
Curator reviewed
Formula / weight: C₁₉H₂₈N₂O₇S₂ · 460.565 g/mol (avg)

Resolves to

Compound

UNIIS57SQE6LE5ChEMBLCHEMBL218382PubChem9804302

Structure

InChIKeyAQSNIXKAKUZPSI-SSTWWWIQSA-NSMILES[H][C@@]1(CC[C@@]2([H])[C@]3([H])CCC4=C(C=C(OC)C(OS(N)(=O)=O)=C4)[C@@]3([H])CC[C@]12C)OS(N)(=O)=O

Targets

P00918CA2P08842STS

What you can answer from here — as of April 02, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with (9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account